Primary Navigation for the CDC Website
CDC en EspaƱol
Division of Reproductive Health: Activities—Maternal and Infant Health Research

 Back to Activities

Approximately six million women become pregnant in the United States each year. CDC is committed to identifying ways to improve women’s health before, during, and after pregnancy, and identifying strategies to improve the health and well-being of newborns and infants. We accomplish this through research and programs that promote healthy lifestyles and improve early detection and prevention among women at risk.

To improve healthy outcomes of women and infants, CDC's Division of Reproductive Health conducts research and surveillance in partnership with multiple federal and non-federal organizations and disseminates key findings. CDC collaborates with partners in state health departments, universities, professional societies, and health maintenance organizations to advance understanding of risk factors, causes, and prevention strategies for the leading causes of maternal and infant death and disability, including preterm birth, sudden unexplained infant death, and acute and chronic complications during pregnancy.

Because major and persistent racial and ethnic disparities exist in pregnancy-related death and illness, preterm birth, and fetal and infant mortality, an essential component of our research focuses on improving understanding of the causes of these conditions and the reasons they affect some subgroups of women disproportionately. Then we can identify new opportunities for prevention and translate new findings into effective public health programs.

Program Highlights

Preterm birth

  • Conducted and published a study that identified preterm birth as the most frequent cause of infant death in the United States, accounting for approximately one third of all infant deaths.
  • In collaboration with outside investigators and state health departments, conduct ongoing research to better understand the social, behavioral, community, genetic, and biologic factors associated with preterm birth and racial disparities, in an effort to identify new opportunities for prevention.
  • Evaluating how 17-alpha hydroxyprogesterone caproate, a progesterone compound for prevention of recurrent preterm birth, is used during routine medical care.

Pregnancy-related complications

  • Evaluating strategies to improve detection, referral, and care of women with a history of gestational diabetes to reduce their high risk for development of type 2 diabetes later in life.
  • Conducting a collaborative study on adverse pregnancy outcomes— placental abruption, preterm delivery, and hypertensive disorders of pregnancy—associated with use of chew tobacco among Alaska Native women.
  • In partnership with state health departments and managed care organizations, improving surveillance and conducting research of pregnancy-related complications, and helping to translate findings into effective prevention programs.

Infant health

  • Revised Guidelines for Death Scene Investigation of Sudden, Unexplained Infant Death in partnership with a national network of participants.
  • Conducted 5 regional train-the-trainer courses across the U.S. to prepare state and local officials in accurate and consistent investigation and reporting of sudden, unexplained infant deaths.

Technical assistance to partners

  • Strengthening and supporting community programs to reduce racial disparities in preterm birth in partnership with the Healthy African American Families Project in Los Angeles, California.
  • Strengthening epidemiologic capacity and public health research in maternal-child health among Native American/Alaska Native populations in partnership with the Indian Health Service and tribal health councils.

Program Impact

  • Through nationwide training of infant death scene investigators, improved reporting of the causes of infant death and increased accuracy of the data used for research to reduce SIDS and other causes of sudden, unexplained infant death.
  • An expanded research agenda for addressing preterm birth that is built on scientific knowledge developed over previous decades and in conjunction with federal and non-federal partners.
  • Accurate information on the health risks of smokeless tobacco use in pregnancy among Alaska Native women to assist local agencies to generate evidence-based health education messages.
  • Improved assessment of antenatal, intrapartum, and postpartum complications and methods for monitoring the pregnancy-related and long-term health of women.
  • Heightened awareness of the importance of intensive maternal death reviews at the state level with the aim of reducing the persistent disparity in pregnancy-related deaths between black and white women.
     

Back to Activities

Page last reviewed: 11/25/08
Page last modified: 7/29/08
Content source: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion

rectangle border

Division of Reproductive Health label

bullet Home
bullet Activities
bullet Organization Chart
bullet Timeline
bullet Contact Us
rectangle border

Reproductive Health related resources
bullet Reproductive Health Home
bullet Data and Statistics
bullet Publications and Products
bullet

Glossary

bullet Related Links

bullet Adolescent Reproductive Health
bullet Assisted Reproductive Technology
bullet Global Reproductive Health
bullet Maternal and Infant Health
bullet Refugee Reproductive Health
bullet Sudden Infant Death Syndrome
bullet Unintended Pregnancy
bullet Women's Reproductive Health

bullet Division of Reproductive Health

Contact Info
CDC/DRH
4770 Buford Hwy, NE
MS K-20
Atlanta, GA 30341-3717

Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760

bullet Contact Us

divider
 
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435
USAGov LogoDHHS Department of Health
and Human Services